日本ケミファの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/06/11 | 2,662 | 2,671 | 2,628 | 2,628 | -34 | -1.3% | 4,100 |
2020/06/10 | 2,699 | 2,699 | 2,661 | 2,662 | -23 | -0.9% | 1,900 |
2020/06/09 | 2,675 | 2,685 | 2,661 | 2,685 | +12 | +0.4% | 1,600 |
2020/06/08 | 2,671 | 2,697 | 2,671 | 2,673 | -15 | -0.6% | 2,100 |
2020/06/05 | 2,725 | 2,725 | 2,688 | 2,688 | -37 | -1.4% | 2,700 |
2020/06/04 | 2,740 | 2,750 | 2,711 | 2,725 | -15 | -0.5% | 2,400 |
2020/06/03 | 2,800 | 2,800 | 2,740 | 2,740 | -60 | -2.1% | 3,300 |
2020/06/02 | 2,752 | 2,800 | 2,726 | 2,800 | +48 | +1.7% | 5,700 |
2020/06/01 | 2,744 | 2,774 | 2,717 | 2,752 | +8 | +0.3% | 3,100 |
2020/05/29 | 2,760 | 2,769 | 2,734 | 2,744 | -16 | -0.6% | 4,500 |
2020/05/28 | 2,731 | 2,780 | 2,704 | 2,760 | +29 | +1.1% | 5,300 |
2020/05/27 | 2,735 | 2,760 | 2,731 | 2,731 | +1 | ±0% | 4,000 |
2020/05/26 | 2,758 | 2,758 | 2,700 | 2,730 | +22 | +0.8% | 3,600 |
2020/05/25 | 2,686 | 2,729 | 2,671 | 2,708 | +22 | +0.8% | 3,900 |
2020/05/22 | 2,612 | 2,723 | 2,612 | 2,686 | +82 | +3.1% | 2,900 |
2020/05/21 | 2,689 | 2,689 | 2,575 | 2,604 | -85 | -3.2% | 4,800 |
2020/05/20 | 2,767 | 2,768 | 2,671 | 2,689 | -78 | -2.8% | 6,100 |
2020/05/19 | 2,910 | 2,930 | 2,750 | 2,767 | +84 | +3.1% | 29,100 |
2020/05/18 | 2,555 | 2,690 | 2,555 | 2,683 | +128 | +5% | 7,300 |
2020/05/15 | 2,588 | 2,588 | 2,523 | 2,555 | -5 | -0.2% | 500 |
2020/05/14 | 2,563 | 2,590 | 2,560 | 2,560 | +6 | +0.2% | 1,900 |
2020/05/13 | 2,557 | 2,557 | 2,554 | 2,554 | +31 | +1.2% | 600 |
2020/05/12 | 2,523 | 2,523 | 2,523 | 2,523 | -50 | -1.9% | 100 |
2020/05/11 | 2,528 | 2,588 | 2,526 | 2,573 | +55 | +2.2% | 800 |
2020/05/08 | 2,598 | 2,598 | 2,493 | 2,518 | -72 | -2.8% | 2,400 |
2020/05/07 | 2,562 | 2,590 | 2,550 | 2,590 | +61 | +2.4% | 1,600 |
2020/05/01 | 2,481 | 2,532 | 2,431 | 2,529 | -49 | -1.9% | 3,500 |
2020/04/30 | 2,384 | 2,578 | 2,384 | 2,578 | +157 | +6.5% | 5,500 |
2020/04/28 | 2,421 | 2,492 | 2,421 | 2,421 | ±0 | ±0% | 5,800 |
2020/04/27 | 2,438 | 2,438 | 2,345 | 2,421 | +83 | +3.6% | 3,400 |
2020/04/24 | 2,300 | 2,338 | 2,300 | 2,338 | -4 | -0.2% | 1,300 |
2020/04/23 | 2,300 | 2,342 | 2,300 | 2,342 | +42 | +1.8% | 1,900 |
2020/04/22 | 2,300 | 2,312 | 2,280 | 2,300 | -15 | -0.6% | 1,700 |
2020/04/21 | 2,400 | 2,400 | 2,315 | 2,315 | -54 | -2.3% | 1,000 |
2020/04/20 | 2,396 | 2,399 | 2,360 | 2,369 | -17 | -0.7% | 1,600 |
2020/04/17 | 2,429 | 2,429 | 2,379 | 2,386 | -5 | -0.2% | 1,600 |
2020/04/16 | 2,433 | 2,433 | 2,330 | 2,391 | -20 | -0.8% | 1,700 |
2020/04/15 | 2,425 | 2,439 | 2,374 | 2,411 | -14 | -0.6% | 1,800 |
2020/04/14 | 2,449 | 2,449 | 2,419 | 2,425 | +6 | +0.2% | 1,400 |
2020/04/13 | 2,380 | 2,452 | 2,380 | 2,419 | +49 | +2.1% | 1,100 |
2020/04/10 | 2,432 | 2,432 | 2,358 | 2,370 | +38 | +1.6% | 2,000 |
2020/04/09 | 2,330 | 2,332 | 2,300 | 2,332 | +2 | +0.1% | 2,000 |
2020/04/08 | 2,350 | 2,360 | 2,280 | 2,330 | -20 | -0.9% | 3,600 |
2020/04/07 | 2,334 | 2,350 | 2,326 | 2,350 | +16 | +0.7% | 2,400 |
2020/04/06 | 2,241 | 2,334 | 2,241 | 2,334 | +91 | +4.1% | 2,600 |
2020/04/03 | 2,362 | 2,362 | 2,139 | 2,243 | -132 | -5.6% | 3,200 |
2020/04/02 | 2,443 | 2,465 | 2,375 | 2,375 | -18 | -0.8% | 1,200 |
2020/04/01 | 2,499 | 2,499 | 2,385 | 2,393 | -82 | -3.3% | 3,600 |
2020/03/31 | 2,544 | 2,544 | 2,450 | 2,475 | -19 | -0.8% | 4,300 |
2020/03/30 | 2,515 | 2,598 | 2,438 | 2,494 | -55 | -2.2% | 10,600 |
1201~
1250
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日ケミファ | 153,000円 | +2.5% | - | 3.27% | 92.00倍 | 0.30倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
シンバイオ | 15,500円 | -24.2% | - | 0.00% | - | 1.95倍 |
|
導入で新薬開発・製品化。抗がん剤「トレアキシン」国内販売。抗ウイルス薬BCVの開発に注力 |
ソレイジア | 3,300円 | +311.4% | - | 0.00% | - | 6.23倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
OTS | 2,300円 | +63.9% | - | 0.00% | - | 6.85倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
ペルセウス | 42,700円 | +20.0% | - | 0.00% | - | 3.58倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体(ADC)開発 |
市場注目の銘柄
チャート関連のコラム